Weng Christina Y

Singer Michael A, Wykoff Charles C, Riemann Christopher D, Gonzalez Victor H, Weng Christina Y, Alkhatib Kamel et al.

The study found that a fluocinolone acetonide implant for DME achieved similar visual and anatomic outcomes to aflibercept, but with fewer total injections, offering a less frequent treatment option.

Smith Justine R, Thorne Jennifer E, Flaxel Christina J, Jain Nieraj, Kim Stephen J, Maguire Maureen G et al.

This review found periocular and intraocular corticosteroids effectively treat noninfectious uveitic macular edema, improving vision and structure, though with risks like elevated eye pressure and cataracts.

Pennesi Mark Edward, Yang Paul, Birch David G, Weng Christina Y, Moore Anthony T, Iannaccone Alessandro et al.

This gene therapy for X-linked retinoschisis was generally safe but showed no measurable clinical benefit in vision, visual fields, or retinal structure, indicating limited efficacy for patients.

Ehlers Justis P, Yeh Steven, Maguire Maureen G, Smith Justine R, Mruthyunjaya Prithvi, Jain Nieraj et al.

This review found anti-VEGF agents and corticosteroids effectively treat DME, but corticosteroids carry IOP/cataract risks. Individualized therapy is crucial due to limited comparative data.

Weng Christina Y, Khimani Karima S, Foroozan Rod, Gospe Sidney M, Bhatti M Tariq

This case showed pars plana vitrectomy successfully treated bilateral vitreopapillary traction, improving vision and resolving retinoschisis, highlighting the importance of distinguishing it from other optic neuropathies.